Executive Summary
Anti-obesity Drugs Market from Consainsights analyses the Anti-obesity Drugs Market in the Technology &
Media industry over the forecast period to 2026.
Anti-obesity Drugs research report from Consainsights outlines the detailed strategic analysis, trends,
market
opportunities, growth prospects, industry and market challenges and sustainable solutions to
sustain in the
competitive environment.
Anti-obesity Drugs segmentation includes Mechanism of Action, Drug Type and Geography.
All segmentations encompasses the key innovations and
micro & macro trends, companies/manufacturers operating in this space along with their usage
and penetration
with respect to the wide range of End Users. Additionally, market sizing information along with
the key factors
such as market drivers, restraints, opportunities and challenges which are likely to be
influencing the market
growth are outlined in this report.
Based on the Mechanism of Action, the Anti-obesity Drugs Market analysis covers Centrally Acting Drugs, Peripherally Acting Drugs.
Based on the Drug Type, the Anti-obesity Drugs Market analysis covers OTC Drugs, Prescription Drugs.
Key companies operating in the market include Alizyme, Rhythm Pharmaceuticals, Eisai Co. Ltd, F. Hoffmann-La Roche AG, Vivus Inc., Takeda Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline PLC, Zydus Cadila, Zafgan, Bayer AG, Novo Nordisk AS, Orexigen Therapeutics, Merck & Co. Inc., Pfizer Inc., Currax Pharmaceuticals LLC, Norgine BV, Arena Pharmaceuticals Inc. and so on. This report
covers the detailed analysis of the company profiles
such as business segments, product portfolio, key brand insights and growth strategies adopted,
company SWOT and
Strategy analysis along with the financial analysis and analyst insights on the key companies
operating in this
market.
Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions,
Partnerships and
so on along with the expansion areas focusing on the additional geographies, future insights for
success and
market share analysis. Major players strategies include the launch of the innovative product
lines along with
the emphasis on the partnerships and acquisitions to standardize their market share in the
market space.
Market Research methodology includes the triangulation of the data from the data sources such as
Primary Market
Research approach and Secondary Market Research Approach along with the data from the trade
bodies and industry
standard publications and data sources. Primary inputs from the industry experts and the market
respondents from
the respective industries to obtain very critical information to assess the future growth
prospects of the
market. The final data is triangulated and thoroughly validated considering all the data sources
using the
bottom-up and the top-down approaches to estimate the market sizing of the individual segments.
Report Metric
|
Details
|
Market size available for years
|
2012-2027
|
Base year considered
|
2021
|
Forecast period
|
2022-2027
|
Forecast units
|
Value (USD Billion)
|
Segments covered
|
Mechanism of Action, Drug Type
|
Geographies covered
|
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
|
Companies Covered
|
Alizyme, Rhythm Pharmaceuticals, Eisai Co. Ltd, F. Hoffmann-La Roche AG, Vivus Inc., Takeda Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline PLC, Zydus Cadila, Zafgan, Bayer AG, Novo Nordisk AS, Orexigen Therapeutics, Merck & Co. Inc., Pfizer Inc., Currax Pharmaceuticals LLC, Norgine BV, Arena Pharmaceuticals Inc.
|
List of Figures & Tables
List of Figures
Figure: Global Anti-obesity Drugs Market: Structure
Figure: Global Anti-obesity Drugs Market: Value Chain Analysis
Figure: Global Anti-obesity Drugs Market: Porter's Five Forces Model
Figure: Global Anti-obesity Drugs Market: Market Dynamics
Figure: Global Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: North America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Europe Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Asia-Pacific Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Latin America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Middle East & Africa Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Global Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: North America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Europe Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Asia-Pacific Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Latin America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
Figure: Middle East & Africa Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)
List of Tables
Table: Global Anti-obesity Drugs Market, By Mechanism of Action, 2017-2026 (USD Million)
Table: North America Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: United States Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Canada Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Europe Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Germany Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: United Kingdom Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: France Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Spain Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Russia Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Italy Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Rest of Europe Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Asia-Pacific Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: China Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Japan Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: India Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Southeast Asia Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Australia & New Zealand Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Rest of Asia-Pacific Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Latin America Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Brazil Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Argentina Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Mexico Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Colombia Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Rest of Latin America Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Middle East & Africa Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Middle East Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Africa Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Rest of Middle East & Africa Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)
Table: Global Anti-obesity Drugs Market, By Drug Type, 2017-2026 (USD Million)
Table: North America Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: United States Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Canada Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Europe Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Germany Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: United Kingdom Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: France Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Spain Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Russia Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Italy Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Rest of Europe Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Asia-Pacific Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: China Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Japan Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: India Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Southeast Asia Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Australia & New Zealand Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Rest of Asia-Pacific Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Latin America Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Brazil Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Argentina Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Mexico Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Colombia Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Rest of Latin America Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Middle East & Africa Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Middle East Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Africa Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)
Table: Rest of Middle East & Africa Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)